US judge denies initial attempt by Novartis to block generic Entresto launch
The court rebuffed claims by Novartis that it would experience 鈥渋rreparable harm鈥� in the absence of an injunction following MSN Pharmaceuticals鈥� generic roll-out.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
